Search - tctmd.com

Displaying 441 - 460 of 568

Sort: Relevancy | Date

Presentation TCT 2014

Prevention of Stent Thrombosis: Devices, Pharmacology, Technique, Patients, and More

Presenter: Stephen G. Ellis, Patrick W. Serruys, Elvin Kedhi, Lorenz Raber

September 14, 2014

Presentation TCT 2014

Aspirin and ADP Antagonists Before and After Coronary Stent Implantation

Presenter: Paul A. Gurbel, Dmitriy N. Feldman

September 14, 2014

Presentation

Aspirin Treatment and Outcomes After PCI

Presenter: Katharina Mayer

August 25, 2014

Presentation

Contemporary Patterns of Discharge Aspirin Dosing After Acute MI in the United States

Presenter: H.M. Hall

August 13, 2014

Presentation LAA 2014

Left Atrial Appendage Closure (LAAC) for Stroke Prevention in Non-Valvular AFib: My Preferred Frontline Therapy

Presenter: Maurice Buchbinder

July 19, 2014

Presentation TVT 2014

PVR Highlights- Etiologies, Diagnosis, Incidence, Clinical Impact, Prevention, and Treatment

Presenter: Susheel Kodali

June 06, 2014

Presentation

Rivaroxaban for Stroke Prevention in East Asian Patients from the ROCKET AF Trial

Presenter: Ka Sing Lawrence Wong

April 29, 2014

Presentation

Prevention of CIN with N-acetylcysteine or Sodium Bicarbonate in Patients with STEMI

Presenter: Per Thayssen

April 15, 2014

Presentation

High On-Treatment Platelet Reactivity as a Risk Factor for Secondary Prevention After Stenting

Presenter: Gilles Montalescot

April 11, 2014

Presentation PCI Outcomes 2014

Atrial Fibrillation and PCI: Antiplatelet Therapy Recommendations

Presenter: Christopher Granger

March 28, 2014

Presentation CTO 2014

Perforation: Type, Prevention, Mechanisms, and Management

Presenter: Georgios Sianos

February 28, 2014

Presentation

Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients

Presenter: Paul Dorian

February 20, 2014

Presentation Cell Therapy 2014

Prevention of Remodeling and CHF after Acute MI: PRESERVATION-I

Presenter: Reinilde Heyrman

January 22, 2014

Presentation

Interventional Approaches to Stroke Prevention in Atrial Fibrillation

Presenter: William A. Gray

December 02, 2013

Presentation

Is Gender a Risk Factor? Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI): Results from the Real-World PARIS Reg

Presenter: Roxana Mehran

December 01, 2013

Presentation

Clinical outcomes associated with dual antiplatelet therapy interruption following implantation of the ResoluteTM zotarolimus-eluting stent

Presenter: Martin T. Rothman

December 01, 2013

Presentation TCT 2013

How the Cardiologist Can Help in Stroke Prevention

Presenter: Leo Nelson Hopkins

October 31, 2013

Presentation TCT 2013

Prevention of Contrast Induced Acute Kidney Injury wtih Ascorbic Acid

Presenter: Umar Sadat

October 30, 2013

Presentation TCT 2013

Neurological Complications of TEVAR: Prevention and Management

Presenter: Michael Dake

October 30, 2013

Presentation TCT 2013

Stroke Prevention During Cardioversion: Are TEEs Needed?

Presenter: Allan Klein

October 29, 2013

Advertisement

Prevention of Stent Thrombosis: Devices, Pharmacology, Technique, Patients, and More

Aspirin and ADP Antagonists Before and After Coronary Stent Implantation

Aspirin Treatment and Outcomes After PCI

Contemporary Patterns of Discharge Aspirin Dosing After Acute MI in the United States

Left Atrial Appendage Closure (LAAC) for Stroke Prevention in Non-Valvular AFib: My Preferred Frontline Therapy

PVR Highlights- Etiologies, Diagnosis, Incidence, Clinical Impact, Prevention, and Treatment

Rivaroxaban for Stroke Prevention in East Asian Patients from the ROCKET AF Trial

Prevention of CIN with N-acetylcysteine or Sodium Bicarbonate in Patients with STEMI

High On-Treatment Platelet Reactivity as a Risk Factor for Secondary Prevention After Stenting

Atrial Fibrillation and PCI: Antiplatelet Therapy Recommendations

Perforation: Type, Prevention, Mechanisms, and Management

Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients

Prevention of Remodeling and CHF after Acute MI: PRESERVATION-I

Interventional Approaches to Stroke Prevention in Atrial Fibrillation

Is Gender a Risk Factor? Incidence and Impact of Dual Antiplatelet Therapy (DAPT) Cessation on Adverse Events following Percutaneous Coronary Intervention (PCI): Results from the Real-World PARIS Reg

Clinical outcomes associated with dual antiplatelet therapy interruption following implantation of the ResoluteTM zotarolimus-eluting stent

How the Cardiologist Can Help in Stroke Prevention

Prevention of Contrast Induced Acute Kidney Injury wtih Ascorbic Acid

Neurological Complications of TEVAR: Prevention and Management

Stroke Prevention During Cardioversion: Are TEEs Needed?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content